Senior insider sale
Chief Development Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$315.4K
10.47K shares
What this filing means
YELESWARAM KRISHNASWAMY plans to sell 10.47K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $315.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/8/2026ACC: 0001950047-26-003340
Officer· Chief Development Officer
Since Feb 2026
10.47K
Shares to sell
$315.4K
Approx. market value
360.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
8/20/2025
360.00Total acquired360.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/20/2025 | Founders Shares N/A | 360.00 | — |
| Total | 360.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10.12K
Market value
$303.4K
3/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
360.00
Market value
$12.1K
4/8/2026
Total
Units
10.47K
Value
$315.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/25/2026 | 10.12K | $303.4K | — | Completed |
| Planned — Approximate Date | ||||
4/8/2026 | 360.00 | $12.1K | NASDAQ | Planned |
| Total | 10.47K | $315.4K | ||